Robert Dickey IV's Net Worth
$49.5 Thousand
Who is Robert Dickey IV?
Robert Dickey IV does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include AngioGenex, Inc., HEMISPHERX BIOPHARMA INC, Emmaus Life Sciences, Inc., NeoStem, Inc., Enveric Biosciences, Inc., EMMAUS LIFE SCIENCES, INC., and Invitae Corp.
SEC CIK
Robert Dickey IV's CIK is 0001466862
Past Insider Trading and Trends
2014 was Robert Dickey IV's most active year for acquiring shares with 5 total transactions. Robert Dickey IV's most active month to acquire stocks was the month of July. 2009 saw Robert Dickey IV paying a total of $1,600.00 for 2,500 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AngioGenex, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HEMISPHERX BIOPHARMA INC (AIM) Snapshot price: $0.3198
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
∞
| 2.5K |
$0.64 | $1,600.00 | 2.5K |
Dec 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Emmaus Life Sciences, Inc. (EMMA) Snapshot price: $0.0875
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NeoStem, Inc. (LSTA) Snapshot price: $3.13
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.18% | 484 |
$3.20 | $1,550.98 | 12.07K |
Dec 31
| |||
Form 4
| +119.40% | 6.3K |
—
|
—
| 11.58K |
Aug 1
| |||
Form 4
| +5.58% | 279 |
$5.54 | $1,546.22 | 5.28K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Aug 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Enveric Biosciences, Inc. (ENVB) Snapshot price: $0.5
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||